(Q36367606)

English

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

based on heuristic

inferred from title

Erb-b2 receptor tyrosine kinase 2

1 reference

based on heuristic

inferred from title

10

object named as

Hitoshi Tsuda

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Hiroaki Nitta

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Brian D Kelly

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Mary Padilla

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Nikolaus Wick

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Patrick Brunhoeber

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Isaac Bai

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Shalini Singh

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jim Ranger-Moore

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Chris Bieniarz

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Thomas M Grogan

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

30 May 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Diagnostic Pathology

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

60

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

30 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Clinical and health economic outcomes of alternative HER2 test strategies for guiding adjuvant trastuzumab therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

30 September 2017

Testing for HER2 in Breast Cancer: A Continuing Evolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

30 September 2017

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

30 September 2017

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

30 September 2017

HER2 testing in the UK: consensus from a national consultation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

30 September 2017

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

30 September 2017

Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

30 September 2017

Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

30 September 2017

Evaluation of dual immunohistochemistry and chromogenic in situ hybridization for HER2 on a single section.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

28 June 2018

Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

28 June 2018

High agreement but low kappa: II. Resolving the paradoxes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

28 June 2018

Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast.

1 reference

https://api.crossref.org/works/10.1186%2F1746-1596-7-60

21 January 2018

HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1746-1596-7-60

21 January 2018

Genetic heterogeneity in HER2 testing may influence therapy eligibility.

1 reference

https://api.crossref.org/works/10.1186%2F1746-1596-7-60

21 January 2018

High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study.

1 reference

https://api.crossref.org/works/10.1186%2F1746-1596-7-60

21 January 2018

Fluorescent in situ hybridization for human epidermal growth factor receptor 2 assessment in breast cancer: is it applicable as a primary test?

1 reference

https://api.crossref.org/works/10.1186%2F1746-1596-7-60

21 January 2018

Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487810

21 September 2018

Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/22647525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Point: Fluorescence in situ hybridization is the preferred approach over immunohistochemistry for determining HER2 status

1 reference

https://pubmed.ncbi.nlm.nih.gov/22647525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 status and benefit from adjuvant trastuzumab in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22647525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer: Should we assess HER2 status by Oncotype DX?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22647525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22647525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratories

1 reference

https://pubmed.ncbi.nlm.nih.gov/22647525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22647525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1746-1596-7-60

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36367606&oldid=2198771666"